Regulatory Command Center
AI Engine: ONLINE
Regulatory Sources: SYNCED
LM
Dr. Laura Martin Regulatory Affairs
1,248
Products
Total portfolio
1,103
Compliant
88.4% of portfolio
97
Under Review
7.8% of portfolio
48
Critical
3.8% of portfolio
€38.4M
Revenue at Risk
Across critical & review items

Regulatory Exposure

Compliant 88.4%
Review Required 7.8%
Critical 3.8%

AI Regulatory Insight

"EU Regulation 2026/1174 creates the highest immediate portfolio exposure. 37 products require action, representing €12.8M annual revenue."

Confidence: 96% 1,248 products scanned

Recent Regulatory Changes

Auto-monitored from 42 regulatory sources
RegulationDescriptionImpactSeverityDeadline
EU Regulation 2026/1174 Restriction of Substance ZX-42 37 products CRITICAL 01 Mar 2027
REACH Annex XVII Update Restriction entry amendment 18 products HIGH 15 Jun 2027
CLP Classification Update Harmonised classification revision 64 products MEDIUM 30 Sep 2027
CLP Update
Jun 2026
EU 2026/1174
Published
REACH Annex XVII
Jun 2027
ZX-42 Limit
01 Mar 2027
Restriction 2027/42
Consultation
ProductProduct CodeBusiness UnitMarket Regulatory StatusRevenueRiskLast Review

No analysis run yet

Click "Run Portfolio Impact Analysis" to let the AI scan the entire product portfolio against EU Regulation 2026/1174.

Connected Knowledge

  • EU Regulations & REACH/CLP text
  • 1,248 product formulations
  • SDS, Labels, Certifications, Dossiers
  • Full audit trail history
All product formulations remain inside your private enterprise environment. No data is sent to public AI services.

Current Formulation

Simulate Change

ZX-42 Stabilizer concentration 0.80%
0.20% Legal limit: 0.50% 1.20%
From0.80%
To0.45%
CP742_SDS_v4.2.pdf OUTDATED
CP742_LABEL_v3.1.pdf OUTDATED
CP742_DOSSIER_v2.0.pdf OUTDATED
CP742_COMPLIANCE_REPORT.pdf NEW

AI Recommendation

"Prioritizing the first 5 products protects approximately 71% of the revenue currently exposed to EU Regulation 2026/1174."

Proposed EU Restriction 2027/42

UNDER CONSULTATION
AI Probability / Confidence
78%
Potential Effective DateQ3 2028
Portfolio Potentially Affected84 products
Potential Revenue Exposure€27.6M
Early Warning

"If the proposed restriction is approved in its current form, 84 products will require reformulation or regulatory review."

Deployment

Private Cloud / On-Premise Ready

Data Sovereignty

Customer Controlled

AI Models

Private Enterprise Models

Product Formulations

Never exposed to public AI services

Auditability

Full AI decision traceability

Access Control

Role-based: Regulatory, R&D, Quality, Product Mgmt

FROM REGULATION TO ACTION Detect. Understand. Simulate. Remediate. Comply.